Southern Kentucky Vascular announced the addition of Shockwave Lithotripsy, becoming the first outpatient vascular center in ...

SANTA CLARA, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...

The long-term effects of treating renal stones with extracorporeal shockwave lithotripsy are not fully known. Potential problems include hypertension, decreased renal function and stone recurrence. A ...

Please provide your email address to receive an email when new articles are posted on . Stone clearance was similar across both studies, regardless of procedure. Patients who underwent shockwave ...

Shockwave Medical's Intravascular Lithotripsy (IVL) system has received premarket approval from the US Food and Drug Administration (FDA) to treat severely calcified coronary artery disease, the ...

Credit: Getty Images. A recent study may support use of tamsulosin as medical expulsion therapy following shockwave lithotripsy. Tamsulosin may be effective as medical expulsive therapy for patients ...

Meta-analysis reveals a significantly increased risk only in male patients. Patients with stones smaller than 7 mm are more likely have a successful treatment than those with larger stones, ...